Tapering Pristiq (Desvenlafaxine Extended-Release) Safely

Recommended Tapering Protocols

For patients on the standard 50 mg daily dose, reduce to 25 mg daily for at least 1-2 weeks before complete discontinuation, applying principles from SNRI tapering guidelines, and monitor closely for withdrawal symptoms during this transition 1
If the patient experiences significant withdrawal symptoms with the standard taper, consider extending the time at each dose level to 2-4 weeks rather than 1-2 weeks, and once at the 25 mg dose, extend the interval between doses (e.g., 25 mg every other day) before complete discontinuation, applying principles used for other medications 2

Watch for discontinuation symptoms including anxiety, irritability, insomnia, dizziness, headache, nausea, and mood changes, and follow-up with the patient at least monthly during the taper, with more frequent contact as needed 1
Consider short-term use of supportive medications such as Trazodone for anxiety or insomnia, Gabapentin for anxiety and sensory symptoms, and Mirtazapine for insomnia and anxiety, used temporarily to ease the transition 3

The minimum tapering duration for most patients will be 2-4 weeks from the standard 50 mg dose, and for patients on higher doses or those with previous withdrawal difficulties, expect 6-8 weeks or longer, with success measured by tolerability and completion, not speed 1, 2